GenSight Biologics
SIGHT.PA
₹23.30
Share price
-2.40%
Change (1 day)
-47.87%
Change (1 year)
Revenue for GenSight Biologics (SIGHT.PA)
Revenue in 2023: ₹0.12 Billion
According to GenSight Biologics's latest financial reports the company's current revenue (TTM 
) is ₹0.12 Billion. In 2023 the company made a revenue of ₹0.12 Billion a decrease over the revenue in the year 2022 that were of ₹0.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GenSight Biologics from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | ₹0.12 B | -49.43% |
| 2022 | ₹0.24 B | -53.65% |
| 2021 | ₹0.52 B | 10.56% |
| 2020 | ₹0.47 B | 589.22% |
| 2019 | ₹68.34 M | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |